FGP
BSX icon

Freestone Grove Partners’s Boston Scientific BSX Stock Holding History

Freestone Grove Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
+28,720
New +$1.56M 0.01% 506
2026
Q1 		– Sell
-1,327,239
Closed -$127M – 1001
2025
Q4 		$127M Buy
1,327,239
+1,254,840
+1,733% +$123M 0.91% 4
2025
Q3 		$7.07M Buy
+72,399
New +$7.5M 0.05% 317
2025
Q2 		– Sell
-3,187
Closed -$322K – 683
2025
Q1 		$322K Sell
3,187
-295,766
-99% -$29.8M ﹤0.01% 465
2024
Q4 		$26.7M Buy
+298,953
New +$26.3M 0.33% 104

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Freestone Grove Partners's BSX Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in Boston Scientific (BSX) in Q2 2026: 28,720 shares worth $1.23M. The stake represents 0.01% of the portfolio and ranks #506 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in BSX as recently as Q4 2025.

Freestone Grove Partners first reported a position in BSX in Q4 2024 and has held it in 5 quarters since. The position peaked at $127M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Freestone Grove Partners held 28,720 shares of Boston Scientific worth $1.23M as of Q2 2026.
  • Boston Scientific was a new Freestone Grove Partners position in Q2 2026.
  • Boston Scientific made up 0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #506 holding.
  • Freestone Grove Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 5 quarters since.
  • Freestone Grove Partners's Boston Scientific position peaked at $127M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.